The Global Automotive Transmission Gears Market Growth Accelerated By Shift Towards Automatic Transmissions

 

Automotive Transmission Gears Market

Automotive transmission gears are mechanical parts that transfer the torque and rotational motion from the engine to the wheels for propelling the vehicle. Automotive transmission gears are essential components used in manual, automatic, and continuous variable transmissions. They help in changing the gear ratio and provide smooth transmission of power to the wheels. The global automotive transmission gear market is growing due to the increasing vehicle production across the world.

 

The global automotive transmission gears market is estimated to be valued at US$ 32909.19 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

Increasing vehicle production is one of the key drivers of the automotive transmission gears market. According to international organization of motor vehicle manufacturers (OICA), global vehicle production rose from around 78.6 million units in 2016 to around 87.2 million units in 2019 at a CAGR of around 2.8%. This growth in vehicle production is fueling the demand for automotive transmission gears. In addition, aging fleet and frequent replacement of old gears are also contributing to the growth of this market.

 

The increasing electrification of vehicle powertrains is expected to provide opportunities for integration of transmission gears in electric vehicles over the forecast period. Electric vehicles require fewer gears compared to conventional internal combustion engine vehicles. However, integration of transmission gears in electric vehicles is expected to drive innovations and new product development in the automotive transmission gears market.

 

SWOT Analysis

Strength: The automotive transmission gears market is witnessing strong demand from OEMs and aftermarket players globally. Stable demand from the automotive industry and increasing adoption of vehicles with automatic transmission are fueling market growth. Manufacturers are focused on developing innovative gear manufacturing technologies to improve gear performance and enhance fuel efficiency.

Weakness: Frequent technological advancements in transmission systems requiring investments in R&D and new manufacturing equipment increase operational costs for manufacturers. Fluctuations in raw material prices also affect the profit margins of players.

Opportunity: Rising demand for electric vehicles provides opportunities for transmission gear manufacturers to develop efficient and durable gears suitable for electric powertrains. Growth in commercial vehicle sales in emerging nations boosts demand. Adoption of lightweight gears using advanced materials to improve fuel efficiency would open new growth avenues.

Threats: Slowdown in the automotive industry due to economic uncertainties poses risks to gear demand. Stringent vehicle emission norms in several countries necessitate efficient transmissions, raising product compliance costs. Trade wars and political instability in key markets threaten supply chain and profitability.

 

Key Takeaways

 

The Global Automotive Transmission Gears Market Share is expected to witness high growth over the forecast period driven by rising vehicle production and sales globally. The global automotive transmission gears market is estimated to be valued at US$ 32909.19 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

The Asia Pacific region currently dominates the market and is expected to maintain its leading position during the forecast period owing to large automotive manufacturing bases in China, India, and Japan. Growing demand for vehicles from expanding middle-class populations and availability of low-cost labor are fueling regional market growth.

 

Key players operating in the automotive transmission gears market are Novartis AG, Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics, Inc., Transgene SA, Cellectis, ImmunityBio, Inc., Sorrento Therapeutics, bluebird bio, Inc., Arcellx, Sana Biotechnology, Inc., Biodesix, Inc, and Laurus Labs. Technological advancements to develop advanced lightweight gears using composite materials and niche application areas like EV powertrains present new revenue opportunities for these companies. Partnerships with OEMs help gain a foothold in lucrative regional markets and maintain leadership. However, trade tensions and fluctuating raw material costs pose challenges.


Get More Insights Here

https://masstamilan.tv/nasal-sprays-in-the-united-states-an-overview/

https://www.ukwebwire.com/automotive-transmission-gears-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

Global Veterinary Equipment and Disposables Market: Trends and Outlook

Image
The veterinary equipment and disposables market is experiencing notable growth and transformation. With the increasing number of pet owners considering their animals as family, there is a growing demand for advanced diagnostic tools, surgical instruments, and consumables in veterinary practices. This trend is also supported by the evolving landscape of veterinary medicine, which now integrates sophisticated equipment like digital radiography and ultrasound. In addition to companion animals, the livestock and poultry industry also relies on specialized veterinary equipment to ensure the health and welfare of animals, contributing to market expansion. Moreover, the emphasis on preventive care and early disease detection has led to a surge in the adoption of veterinary equipment and diagnostics for routine check-ups. The incorporation of technology in veterinary practices, including electronic health records and telemedicine, is further enhancing the efficiency and quality of animal healt
Read more

"Vaginal Slings Market: A Comprehensive Analysis of Growth Trends and Opportunities"

Image
  In recent years, the vaginal slings market has seen significant growth and innovation. Vaginal slings, also known as pelvic organ prolapse (POP) slings or mesh, are medical devices used to treat stress urinary incontinence and POP in women. These conditions can greatly impact a woman's quality of life, and vaginal slings have become a key solution. The market has witnessed the introduction of various materials and designs to enhance effectiveness and reduce complications. One notable trend in the vaginal slings market is the shift towards using biocompatible materials, such as polypropylene, to reduce the risk of adverse reactions. Additionally, newer sling designs aim to improve surgical outcomes, minimize discomfort, and ensure long-term efficacy. The choice between different types of vaginal slings, including retropubic and transobturator slings, allows for personalized treatment options based on individual patient needs. Furthermore, increased awareness of the importance
Read more

The Global Stem Cell Banking Market is Anticipated to Witness Considerable Growth Due to Rising Awareness About Stem Cell Therapies

Image
  stem cell banking market Stem cell banking is the process of collecting, processing and storing of stem cells, commonly from umbilical cord blood and tissue for future use in transplantation and research activities. Stem cells present in umbilical cord blood offer advantages like lower risk of transmitting infections, higher proliferation potential, and ability to treat a wider range of blood and immune disorders. Cord blood is collected from the umbilical cord and placenta after birth and the stem cells within are isolated and cryogenically frozen and stored in specialized stem cell banks for future medical need. The global stem cell banking market size was valued at US$ 616.11 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 -2030.   Key players operating in the stem cell banking market are CM Fine Chemicals GmbH, Hawks Chemical Company, Hebei Yingong New Material Technology Co., Ltd., Heranba Industries Ltd., Jiangsu Dacheng Pharmaceutical a
Read more